Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • December 2006 | Volume 19 - Issue 12
    By Michael S. Downey, DPM, FACFAS
    35,622 reads | 0 comments | 12/03/06
         Charcot osteoarthropathy remains a chronic, progressive and destructive process that often affects the bony architecture and joints of the foot and ankle, primarily in patients with diabetic peripheral neuropathy. Despite advances in the diagnosis and management of this condition, the deformity continues to be associated with a high incidence of recurrence, treatment failure and resultant morbidity. If left untreated, Charcot foot predictably leads to deformity, ulceration, infection and amputation.      The mainstays of treatment for the Charcot foot hav ... continue reading
    By Jared Wilkinson, DPM, Michael Palladino, DPM, and Peter Blume, DPM
    26,032 reads | 0 comments | 12/03/06
          As the diabetic population continues to swell worldwide, there has also been an increased occurrence of various cutaneous manifestations associated with the disease. Researchers have reported a greater than 30 percent incidence of these disorders and they have been found in up to 70 percent of all patients with diabetes at some point during the course of their illness.1-5 Another problematic statistic for the diabetic population is the fact that 15 percent of all people with diabetes will experience at least one ulceration during their lifetime.6 ... continue reading